The last year (and particularly the last few months) of the Biden Administration brought a flurry of activity from the Federal Trade Commission ...

Johnson & Johnson may outshine AbbVie as a top defensive stock pick. Read how Ben Graham's framework evaluates each ...

AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...

AbbVie Inc. closed 5.34% below its 52-week high of $207.32, which the company reached on October 31st.

In this Healio Video Perspective from Telling It Like It Is, I. Paul Singh, MD, discusses utilizing the “robust” portfolio of ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...